SPC467
Elranatamab
Status:
UmsóknApplication date:
6.5.2024Application published:
15.6.2024
Max expiry date:
7.12.2038Medicine name:
ElrexfioMedicine for children:
No
Timeline
Today
6.5.2024Application
15.6.2024Publication
7.12.2038Expires
Marketing license
IS authorization number:
EU/1/23/1770Date:
18.12.2023
Foreign authorization number:
EU/1/23/1770Date:
7.12.2023
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3283106